Intrinsic Value

Sorrento Therapeutics, Inc. (SRNE)

$0.015

+0.00 (+7.14%)

Enterprise Value -28,238.56
Net Debt 110.87
Equity Value -28,349.43
Shares Outstanding 419.31
Equity Value Per Share -67.61



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt